201 related articles for article (PubMed ID: 22859935)
1. Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.
Zhen A; Du J; Zhou X; Xiong Y; Yu XF
PLoS One; 2012; 7(7):e38771. PubMed ID: 22859935
[TBL] [Abstract][Full Text] [Related]
2. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
Binka M; Ooms M; Steward M; Simon V
J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
[TBL] [Abstract][Full Text] [Related]
3. The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity.
Ooms M; Majdak S; Seibert CW; Harari A; Simon V
J Virol; 2010 Aug; 84(16):7961-9. PubMed ID: 20519396
[TBL] [Abstract][Full Text] [Related]
4. Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.
Bohn JA; DaSilva J; Kharytonchyk S; Mercedes M; Vosters J; Telesnitsky A; Hatziioannou T; Smith JL
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578294
[TBL] [Abstract][Full Text] [Related]
5. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.
Zhen A; Wang T; Zhao K; Xiong Y; Yu XF
J Virol; 2010 Feb; 84(4):1902-11. PubMed ID: 19939923
[TBL] [Abstract][Full Text] [Related]
6. The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.
Ooms M; Letko M; Binka M; Simon V
PLoS One; 2013; 8(2):e57744. PubMed ID: 23469063
[TBL] [Abstract][Full Text] [Related]
7. Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.
Mitra M; Singer D; Mano Y; Hritz J; Nam G; Gorelick RJ; Byeon IJ; Gronenborn AM; Iwatani Y; Levin JG
Retrovirology; 2015 Jan; 12():3. PubMed ID: 25614027
[TBL] [Abstract][Full Text] [Related]
8. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
10. The Structural Interface between HIV-1 Vif and Human APOBEC3H.
Ooms M; Letko M; Simon V
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031368
[TBL] [Abstract][Full Text] [Related]
11. Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles.
Tian C; Wang T; Zhang W; Yu XF
Nucleic Acids Res; 2007; 35(21):7288-302. PubMed ID: 17959647
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.
Wang X; Abudu A; Son S; Dang Y; Venta PJ; Zheng YH
J Virol; 2011 Apr; 85(7):3142-52. PubMed ID: 21270145
[TBL] [Abstract][Full Text] [Related]
13. The Role of RNA in HIV-1 Vif-Mediated Degradation of APOBEC3H.
Wang J; Becker JT; Shi K; Lauer KV; Salamango DJ; Aihara H; Shaban NM; Harris RS
J Mol Biol; 2019 Dec; 431(24):5019-5031. PubMed ID: 31628948
[TBL] [Abstract][Full Text] [Related]
14. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.
Zhang W; Du J; Yu K; Wang T; Yong X; Yu XF
J Virol; 2010 Dec; 84(24):12903-13. PubMed ID: 20926562
[TBL] [Abstract][Full Text] [Related]
15. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.
Wang T; Tian C; Zhang W; Sarkis PT; Yu XF
J Mol Biol; 2008 Jan; 375(4):1098-112. PubMed ID: 18067920
[TBL] [Abstract][Full Text] [Related]
16. Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif.
Nakashima M; Tsuzuki S; Awazu H; Hamano A; Okada A; Ode H; Maejima M; Hachiya A; Yokomaku Y; Watanabe N; Akari H; Iwatani Y
J Mol Biol; 2017 Apr; 429(8):1262-1276. PubMed ID: 28336404
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
18. Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles.
Didierlaurent L; Racine PJ; Houzet L; Chamontin C; Berkhout B; Mougel M
Nucleic Acids Res; 2011 Nov; 39(20):8915-27. PubMed ID: 21791531
[TBL] [Abstract][Full Text] [Related]
19. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
[TBL] [Abstract][Full Text] [Related]
20. Characterization of APOBEC3G binding to 7SL RNA.
Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]